Drug treatment of anxiety
Vinar, O.
Agressologie Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 22(C): 35-38
1981
ISSN/ISBN: 0002-1148 PMID: 7325294 Document Number: 179561
Document emailed within 1 workday
Related Documents
Taheri Zadeh, Z.; Rahmani, S.; Alidadi, F.; Joushi, S.; Esmaeilpour, K. 2021: Depresssion, anxiety and other cognitive consequences of social isolation: Drug and non-drug treatments International Journal of Clinical Practice 75(12): E14949Riemann, D. 1996: Anxiety disorders. Diagnosis and therapy in family practice. 1: Anxiety reactions--psychiatric disorders and anxiety--anxiety disorders Fortschritte der Medizin 114(33): 457-459
Moxnes, P.; Kann, F. 1979: The book "Anxiety and Organization": if we don't have management anxiety we suffer from systems anxiety Sygeplejersken 79(43): 12-14
Salzman, C.; Goldenberg, I.; Bruce, S.E.; Keller, M.B. 2001: Pharmacologic treatment of anxiety disorders in 1989 versus 1996: results from the Harvard/Brown anxiety disorders research program Journal of Clinical Psychiatry 62(3): 149-152
Bourin, M.; Hascoët, M. 2001: Drug mechanisms in anxiety Current Opinion in Investigational Drugs 2(2): 259-265
Bratfos, O. 1979: Drug therapy of anxiety Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 99(6): 333-334
Lindqvist, P.; Palmstierna, T.; Franck, J.; Romelsjö, A. 2003: Anxiety and depression are often drug-related Lakartidningen 100(23): 2080-2082
Henry, B.W.; Overall, J.E.; Markette, J.R. 1971: Comparison of major drug therapies for alleviation of anxiety and depression Diseases of the Nervous System 32(10): 655-667
2010: Special lavender oil. New phytotherapy anxiolytic drug for sub-syndromal anxiety disorders MMW Fortschritte der Medizin 152(9): 86-87
Faludi, Gábor.; Gonda, Xénia.; Döme, Péter. 2015: An update on the conceptual and classification issues of anxiety, its neuroanatomy and problems of anxiolytic drug discovery Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 17(2): 69-80
Fogel, B.S.; Fretwell, M.D. 1991: Common mental health problems in geriatric practice. Part I: Dementia, depression, anxiety, and prescription drug toxicity Rhode Island Medical Journal 74(2): 62-67
James, I.M. 1984: Practical aspects of the use of beta-blockers in anxiety states: situational anxiety Postgraduate Medical Journal 60(Suppl 2): 19-25
Hallstrom, C. 1984: Practical aspects of the use of beta-blockers in anxiety stress: morbid anxiety Postgraduate Medical Journal 60(Suppl 2): 26-28
Ak, S.ç; Kılıç, C. 2017: Does Gender Affect the Relationship Between Anxiety Sensitivity and Social Anxiety? Turk Psikiyatri Dergisi 28(4): 240-245
Motak, E. 1987: The DSM IIi classification of anxiety disorders in the light of psychological models of anxiety Psychiatria Polska 21(6): 533-539
Chevalier, A.; Bonenfant, S.; Picot, M.C.; Chastang, J.F.; Luce, D. 1996: Occupational factors of anxiety and depressive disorders in the French National Electricity and Gas Company. The Anxiety-Depression Group Journal of Occupational and Environmental Medicine 38(11): 1098-1107
Jalbout, N.; Karam, A.N.; Karam, E.; Feghaly, C.; Khalaf, H. 1994: Premedication with Midazolam (Dormicum) compared with Promethazine, Droperidol and placebo in relieving anxiety using Beck's anxiety inventory Le Journal Medical Libanais. Lebanese Medical Journal 42(2): 69-73
Videbech, M.; Carlsson, P.S.; Jensen, N.Christian.; Videbech, P. 2003: Measuring of preoperative anxiety by three self-reporting scales: State Trait Anxiety Inventory, Symptoms CheckList 92 and visual analogue scale Ugeskrift for Laeger 165(6): 569-574
Landén, M. 2001: Does smoking cause anxiety or does anxiety make us smoke? Lakartidningen 98(15): 1806
Danion, J.M.; Singer, L. 1983: Treatment of generalized anxiety L'Encephale 9(4 Suppl 2: 307b-312b